Earlier this month, the US Centers for Disease Control approved a recommendation that children between five and eleven years old receive a pediatric dose of the Pfizer BioNTech vaccine.

本月早些时候，美国疾病控制中心批准了一项建议，即5至11岁的儿童可以接种儿童剂量的辉瑞生物科技疫苗。